Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

FDA approves first orally-administered faecal microbiota product for preventing serious gut infection

April 27, 2023 Medical Communications

The US Food and Drug Administration (FDA) has announced that it has approved the first orally-ingested faecal microbiota product for …
News
anirudh-djo3injpaoe-unsplash_3

NICE recommends two CAR T treatments for blood cancers to the Cancer Drugs Fund

April 27, 2023 Medical Communications

The National Institute for Health and Care Excellence (NICE) has announced that it is recommending two personalised immunotherapy treatments to …
News

FDA shares safety warning on amniotic fluid eyedrops

April 26, 2023 Medical Communications

The US Food and Drug Administration (FDA) has released a Public Safety Notification on eyedrops containing amniotic fluid currently being …
News
max-bender-w5bn80xghre-unsplash_1

FDA grants accelerated approval for QALSODY (tofersen) as ALS treatment

April 26, 2023 Medical Communications

Biogen has announced that the US Food and Drug Administration (FDA) has approved QALSODY (tofersen) 100mg/15ml injection for the treatment …
News
national-cancer-institute-l8twzt4ccvq-unsplash_1

UCB and Huma Therapeutics collaborate on digital health solution to improve rare disease management

April 26, 2023 Medical Communications

Digital health company Huma Therapeutics and biopharmaceutical company UCB are partnering to offer a digital technology solution to aid patients …
News
jair-lazaro-0lrjo37r6nk-unsplash

Abbott announces two FDA clearances for life support system

April 26, 2023 Medical Communications

US-based medical devices and healthcare company Abbott has announced two new clearances from the US Food and Drug Administration (FDA) …
News
national-cancer-institute-kmvohcb-w5g-unsplash_1

EMA validates marketing authorisation application for Jemperli with chemotherapy

April 25, 2023 Medical Communications

GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication …
News
hal-gatewood-_jbclosdsd4-unsplash

NICE publishes Final Appraisal Document for multiple myeloma drug

April 25, 2023 Medical Communications

The National Institute for Health and Care Excellence (NICE) has submitted a Final Appraisal Document (FAD) for the use of …
News
robina-weermeijer-so1l3jsdd3y-unsplash_2

AstraZeneca and Ionis share positive results from phase 3 trial for eplontersen

April 25, 2023 Medical Communications

AstraZeneca and Ionis have announced positive results from their phase 3 NEURO-TTRansform trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy …
News
national-cancer-institute-9k4fglw6efq-unsplash

NICE recommends treatment combination for advanced leukaemia

April 24, 2023 Medical Communications

The National Institute for Health and Care Excellence (NICE) has recommended Janssen’s imbruvica (ibrutinib) alongside venetoclax as a treatment option …
News
mufid-majnun-cm1au42fnrg-unsplash_3

Sanofi offers hepatitis A vaccine for UK children

April 24, 2023 Medical Communications

Sanofi has introduced a hepatitis A vaccine for children aged between one to 15 years old in the UK. The …
News
markus-spiske-hvsr_cvecvi-unsplash

Aptar and Healint announce collaboration on CNS and immune system conditions management

April 24, 2023 Medical Communications

AI healthcare company Healint and Software as a Medical Device (SaMD) expert Aptar Digital Health have announced a collaboration aiming …
News

RetinAI and Boehringer Ingelheim partner over AI treatments for geographic atrophy

April 21, 2023 Medical Communications

Swiss data management software company RetinAI and US-based Boehringer Ingelheim have announced a partnership to improve patient outcomes in geographic …
News

FDA awards clearance to Meridian Bioscience for Curian Shiga Toxin assay

April 21, 2023 Medical Communications

Meridian Bioscience, a US-based diagnostic testing solutions provider, has announced that the FDA has given clearance for its new Curian …
News
solen-feyissa-xfnfmlnpwdo-unsplash

Johnson & Johnson warns of dangers of Benadryl TikTok challenge

April 20, 2023 Medical Communications

Following the death of a 13-year-old boy who took part in an online “challenge” to take a large amount of …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025